Lung Volume Reduction Surgery for Patients with Alpha-1 Antitrypsin Deficiency Emphysema

Thoracic Surgery Clinics

Volumn 19, Issue 2, 2009, Pages 201-208

  Donahue, James M ^a   Cassivi, Stephen D ^b  

^a UNIVERSITY OF MARYLAND   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Alpha 1 antitrypsin deficiency; Emphysema; Lung volume reduction surgery; Surgery

Indexed keywords

ALPHA 1 ANTITRYPSIN; LEUKOCYTE ELASTASE; TRYPSIN;

ALPHA 1 ANTITRYPSIN DEFICIENCY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; EMPHYSEMA; FORCED EXPIRATORY VOLUME; GENETIC DISORDER; HUMAN; INCIDENCE; LUNG PARENCHYMA; LUNG RESECTION; LUNG TRANSPLANTATION; PALLIATIVE THERAPY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVIEW; SURVIVAL;

ALPHA 1-ANTITRYPSIN DEFICIENCY; HUMANS; LUNG TRANSPLANTATION; PATIENT SELECTION; PNEUMONECTOMY; PULMONARY EMPHYSEMA; TREATMENT OUTCOME;

EID: 66249110336     PISSN: 15474127     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thorsurg.2009.02.002     Document Type: Review

References (42)

1. Laurell C.-B., and Eriksson A. The electrophoretic alpha 1-globulin pattern of serum in alpha 1-antitrypsin deficiency. Scand J Clin Lab Invest 15 (1963) 132-140
2. Stoller J.K., and Aboussouan L.S. Alpha 1-antitrypson deficiency. Lancet 365 (2005) 2225-2236
3. Lethbridge-Cejku M, Schiller JS, Bernadel L. Vital and Health Statistics, series 10, number 222: summary health statistics for US adults-National Health Interview Survey, 2002. Hyattsville (MD): National Center for Health Statistics, 2004. Available at: http://www.cdc.gov/nchs/data/series/sr_10/sr10_222.pdf. Accessed April 18, 2008.
4. Lieberman J., Winter B., and Sastre A. Alpha 1-antitrypsin Pi-types in 965 COPD patients. Chest 89 (1986) 370-373
5. DeMeo D.L., and Silverman E.K. Alpha 1-antitrypsin deficiency, 2:genetic aspects of alpha(1)-antitrypsin deficiency: phenotypes and genetic modifiers of emphysema risk. Thorax 59 (2004) 259-264
6. Eriksson S. A 30-year perspective on alpha 1-antitrypsin deficiency. Chest 110 Suppl 6 (1996) 237S-242S
7. Gadek J.E., and Crystal R.G. Alpha 1-antitrypsin deficiency. In: Stanbury J.B., Wyngaarden J.B., Frederickson D.S., et al. (Eds). The metabolic basis of inherited disease (1983), McGraw-Hill, New York 1450-1467
8. Tobin M.J., Cook P.J., and Hutchison D.C. Alpha 1 antitrypsin deficiency: the clinical and physiological features of pulmonary emphysema in subjects homozygous for Pi type Z-a survey by the British Thoracic Association. Br J Dis Chest 77 (1983) 14-27
9. Stockley R.A., Bayley D.L., Unsal I., et al. The effect of augmentation therapy on bronchial inflammation in alpha 1-antitrypsin deficiency. Am J Respir Crit Care Med 165 (2002) 1494-1498
10. Aldonyte R., Jansson L., and Janciauskiene S. Concentration-dependent effects of native and polymerized alpha 1-antityrpsin on primary human monocytes, in vitro. BMC Cell Biol 5 (2004) 11
11. Janciauskiene S., Larsson S., Larsson P., et al. Inhibition of lipopolysaccharide-mediated human monocyte activation, in vitro, by alpha 1-antitrypsin. Biochem Biophys Res Commun 321 (2004) 592-600
12. Lomas D.A., and Mahadeva R. Alpha 1-antitrypsin polymerization and the serpinopathies: pathobiology and prospects for therapy. J Clin Invest 110 (2002) 1585-1590
13. Stecenko A., and Brigham K.L. Gene therapy progress and prospects: alpha-1 antitrypsin. Gene Ther 10 (2003) 95-99
14. Stavngaard T., Shaker S.B., and Dirksen A. Quantitative assessment of emphysema distribution in smokers and patients with alpha1-antitrypsin deficiency. Respir Med 100 1 (2006) 94-100
15. Parr D.G., Stoel B.C., Stolk J., et al. Pattern of emphysema distribution in alpha 1-antitrypsin deficiency influences lung function impairment. Am J Respir Crit Care Med 170 11 (2004) 1172-1178
16. 1-antitrypsin deficiency. Chest 111 (1997) 394-403
17. Stoller J.K., Smith P., Yang P., et al. Physical and social impact of alpha-1 antitrypsin deficiency: results of a survey. Cleve Clin J Med 61 (1994) 461-467
18. Silverman E.K., Miletich J.P., Pierce J.A., et al. Alpha 1-antitrypsin deficiency: high prevalence in the St. Louis area determined by direct population screening. Am Rev Respir Dis 140 (1989) 961-966
19. Luisetti M., and Seersholm N. Alpha 1-antitripsin deficiency, 1: epidemiology of alpha 1-antitrypsin deficiency. Thorax 59 (2004) 164-169
20. American Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency. Am J Respir Crit Care Med 168 (2003) 818-900
21. The Alpha-1 antitrypsin Deficiency Registry Study Group. A registry of patients with severe deficiency of alpha 1-antitrypsin: design and methods. Chest 106 (1994) 1223-1232
22. Alpha 1-Antitrypsin Deficiency Registry Study Group. Survival and FEV1 decline in individuals with severe deficiency of alpha1-antitrypsin. Am J Respir Crit Care Med 158 (1998) 49-59
23. Trulock E.P., Christie J.D., Edwards L.B., et al. Registry of the International Society for Heart and Lunch Transplantation: twenty-fourth Official Adult Lung and Heart-Lung Transplantation Report-2007. J Heart Lung Transplant 26 (2007) 782-795
24. Cassivi S.D., Meyers B.F., Battafarano R.J., et al. Thirteen-year experience in lung transplantation for emphysema. Ann Thorac Surg 74 (2002) 1663-1670
25. de Perrot M., Chaparro C., McRae K., et al. Twenty-year experience of lung transplantation at a single center: influence of recipient diagnosis on long-term survival. J Thorac Cardiovasc Surg 127 (2004) 1493-1501
26. Meyer K.C., Nunley D.R., Dauber J.H., et al. Neutrophils, unopposed neutrophil elastase and alpha 1-antprotease defenses following human lung transplantation. Am J Respir Crit Care Med 164 (2001) 97-102
27. 1-antitrypsin deficiency emphysema. Chest 110 (1996) 284S-294S
28. Brantigan O.C., Mueller E., and Kress M.B. A surgical approach to pulmonary emphysema. Am Rev Respir Dis 80 (1959) 194-206
29. Cooper J.D., Patterson G.A., Sundaresan R.S., et al. Results of 150 consecutive bilateral lung volume reduction procedures in patients with severe emphysema. J Thorac Cardiovasc Surg 112 (1996) 1319-1330
30. Ciccone A.M., Meyers B.F., Guthrie T.J., et al. Long-term outcome of bilateral lung volume reduction in 250 consecutive patients with emphysema. J Thorac Cardiovasc Surg 125 (2003) 513-525
31. Fishman F., Martinez F., Naunheim K., et al. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med 348 (2003) 2059-2073
32. McKenna R.J., Benfitt J.O., DeCamp M., et al. Safety and efficacy of median sternotomy versus video-assisted thoracic surgery for lung volume reduction surgery. J Thorac Cardiovasc Surg 127 5 (2004) 1350-1360
33. Stoller J.K., Gildea T.R., Ries A.L., et al. Lung volume reduction surgery in patients with emphysema and α-1 antitrypsin deficiency. Ann Thorac Surg 83 (2007) 241-251
34. Naunheim K.S., Keller C.A., Krucylak P.E., et al. Unilateral video-assisted thoracic surgical lung reduction. Ann Thorac Surg 61 (1996) 1092-1098
35. 1-antitrypsin deficiency versus smokers emphysema. Eur Respir J 12 (1998) 1028-1032
36. 1-antitrypsin emphysema. Eur Respir J 14 (1999) 928-933
37. 1-antitrypsin deficiency. J Thorac Cardiovasc Surg 128 (2004) 408-413
38. Dauriat G., Mal H., Jebrak G., et al. Functional results of unilateral lung volume reduction surgery in alpha1-antitrypsin deficient patients. Int J Chron Obstruct Pulmon Dis 1 2 (2006) 201-206
39. Meyers B.F., Yusen R.D., Guthrie T.J., et al. Outcome of bilateral lung volume reduction in patients with emphysema potentially eligible for lung transplantation. J Thorac Cardiovasc Surg 122 (2001) 10-17
40. Zenati M., Keenan R.J., Courcoulas A.P., et al. Lung volume reduction or lung transplantation for end-state pulmonary emphysema. Eur J Cardiothorac Surg 14 (1998) 27-32
41. Todd T.R., Perron J., Winton T.L., et al. Simultaneous single-lung transplantation and lung volume reduction. Ann Thorac Surg 63 5 (1997) 1468-1470
42. Hamacher J., Russi E.W., and Weder W. Lung volume reduction surgery: a survey on the European experience. Chest 117 6 (2000) 1560-1567